Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 8,034 | 1,169 | 1,464 | 4,026 | 3,188 |
| Cost of Goods | 5,199 | 885 | 661 | 283 | 895 |
| Gross Profit | 2,835 | 284 | 803 | 3,743 | 2,293 |
| Operating Expenses | 15,812 | 20,550 | 18,334 | 18,341 | 21,808 |
| Operating Income | -12,778 | -19,381 | -16,870 | -14,315 | -18,620 |
| Interest Expense | 47 | 5 | 0 | 747 | 1,319 |
| Other Income | 6,675 | -9,485 | 3,400 | -619 | 340 |
| Pre-tax Income | -6,150 | -28,871 | -13,470 | -15,681 | -19,599 |
| Income Tax | -124 | 2 | 10 | 26 | 25 |
| Net Income Continuous | -6,026 | -28,873 | -13,480 | -15,707 | -19,624 |
| Minority Interests | -1,371 | -68 | N/A | N/A | N/A |
| Net Income | $-4,655 | $-28,805 | $-13,480 | $-15,707 | $-19,624 |
| EPS Basic Total Ops | -18.80 | -181.20 | -143.20 | -291.20 | -354.00 |
| EPS Basic Continuous Ops | -24.20 | -181.51 | -143.18 | -291.41 | -353.90 |
| EPS Diluted Total Ops | -18.80 | -181.20 | -143.20 | -291.20 | -354.00 |
| EPS Diluted Continuous Ops | -24.20 | -181.51 | -143.18 | -291.41 | -353.90 |
| EPS Diluted Before Non-Recurring Items | -64.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,112 | $-18,659 | $-16,909 | $-14,125 | $-18,176 |